Results 1 to 10 of about 4,921 (152)

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2018
ABSTRACT A total of 46 clinical isolates of Candida guilliermondii and Candida famata were reidentified genetically, resulting in 27 C. guilliermondii and 12 Candida fermentati strains. The majority of C. guilliermondii
Takahiro Takazono   +2 more
exaly   +7 more sources

Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol [PDF]

open access: yesVeterinary World, 2021
Background and Aim: Different Candida species isolated in humans and animals have different types of parasite activity. The most pathogenic species is Candida albicans followed by Candida tropicalis.
Nadezhda Sachivkina   +2 more
doaj   +5 more sources

Disruption of Protein Mannosylation Affects Candida guilliermondii Cell Wall, Immune Sensing, and Virulence [PDF]

open access: yesFrontiers in Microbiology, 2016
The fungal cell wall contains glycoproteins that interact with the host immune system. In the prominent pathogenic yeast Candida albicans, Pmr1 acts as a Golgi-resident ion pump that provides cofactors to mannosyltransferases, regulating the synthesis of
Nicolas Papon   +2 more
exaly   +4 more sources

Candida guilliermondii as the aetiology of candidosis Candida guilliermondii como agente de candidose [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2006
Candida guilliermondii is one of the components of human microbiota. This yeast has been infrequently associated with human infections, which may be related to its low pathogenicity.
Alessandro Comarú Pasqualotto   +2 more
doaj   +6 more sources

Management of Candida guilliermondii joint infection in a dog. [PDF]

open access: yesActa Vet Scand, 2016
Candida spp. are dimorphic fungi in the family Cryptococcaceae. Infections with Candida spp. are usually rare conditions in dogs, but immunocompromised patients have a higher risk for developing invasive candidal infections.A 5-year-old male Boxer, positive to Leishmania infantum, was referred to the Veterinary Teaching Hospital of the Department of ...
Bufalari A   +7 more
europepmc   +5 more sources

Experimental therapy with azoles against Candida guilliermondii. [PDF]

open access: yesAntimicrob Agents Chemother, 2014
ABSTRACT We evaluated the in vitro killing activity of voriconazole (VRC) and posaconazole (PSC) against two clinical isolates of Candida guilliermondii . The two drugs showed fungistatic activity against both isolates and were effective in reducing kidney fungal burden in a ...
Sanchis M   +5 more
europepmc   +4 more sources

Carvacrol Reduces Virulence Traits in Meyerozyma guilliermondii and Candida dubliniensis and Enhances Galleria mellonella Survival During Candidozyma auris Infection [PDF]

open access: yesMicroorganisms
Background: Antifungal resistance among Candida species and related genera, coupled with the lack of new drugs, poses a significant threat to public health.
Andrea Giammarino   +6 more
doaj   +2 more sources

Clinical Isolates of Candida guilliermondii Include Candida fermentati [PDF]

open access: yesInternational Journal of Systematic Bacteriology, 1997
Clinical isolates of Candida guilliermondii that were investigated by isoenzyme and randomly amplified polymorphic DNA analyses represented two distinct species. The two species were distinguished on the basis of delayed fermentation of galactose. The larger group of isolates was closely related to the anamorph C.
R M, San Millán   +3 more
openaire   +2 more sources

Onychomycosis caused by Pichia guilliermondii: A case report and mini-review

open access: yesMedical Mycology Case Reports, 2020
Onychomycosis has been reported to be mainly caused by dermatophytes. Recently, more attention has been paid to yeast for its increasing morbidity, especially the candida specices.
Mei-jie Zhang   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy